It seems no time since we gathered in our 52nd year in Philadelphia to hold our 2016 Annual Meeting, and now here we are in May 2017, looking forward to meeting next month in Chicago for this year's Annual Meeting, themed "Driving Insights to Action." As noted on our web site, 1 this annual meeting is "the largest, longest-running event in the life sciences industry designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies." This is an achievement to acknowledge and celebrate, and it's also appropriate to remember that we have over 12,000 active global members from various stakeholder groups, including the biopharmaceutical Developing clinically relevant quality specifications Impact of global harmonization on continuous improvement and optimization of manufacturing Comparison of inspection findings and recommendations of registration trials submitted in support of marketing applications of new drug products to EMA and FDA.
Hot topic: Clinical Operations Benefits and challenges of Master Protocols and multicompany collaborations
Improving retention as well as recruitment Audits and agency inspections of risk-based monitored studies-the results are in! industry, government agencies (including regulatory agencies), students, and, importantly and increasingly, patient groups. Table 1 provides an easily digested overview of the 12 tracks at this year's meeting and provides examples of highlights. A quick glance ahead of more detailed reading reveals the tremendous diversity of content that the program committee has built into the meeting: professionals and students from all walks of biopharmaceutical and medical device endeavors will find multiple sessions of interest and benefit.
There are also several educational formats this year, some continuing from previous years and some being employed for the first time. Consider first two formats that were used at last year's meeting, Engage and Exchange (E&E) and DIAmond Sessions. E&E sessions, which are limited to 50 participants, are structured with a 10-minute didactic presentation, 20-30 minutes of group discussion, and 10-20 minutes of wrap-up and information sharing. DIAmond sessions, offered on Monday, Tuesday, Wednesday, and Thursday mornings, will bring together key innovators from industry, academia, and government agencies to discuss strategies to meet today's priorities and prepare for the next generation of challenges in our field.
Two new session formats are the Content Hub and the Career Fair. The Content Hub provides attendees with the opportunity to interact with speakers and session leaders, to gain deeper insights into content presented earlier in the meeting. These sessions are designed for 30-minute short presentations, and seating is limited to an intimate audience of 30 people, thereby facilitating the opportunity for attendees to participate in active "Question & Answer" sessions. At the Career Fair on Saturday June 18th-the first complimentary fair hosted during a DIA Global Annual Meeting-meeting attendees will be able to mingle with leading employers in the clinical and product development space who will be showcasing the career opportunities available within their organizations. This is your rare chance to connect with pharma, biotech, and CRO organizations all in one venue. Whether you are a recent graduate or a seasoned professional, the DIA Career Fair is the premier event to discover your next career move.
Our 2017 meeting therefore promises to be a mixture of established and new ideas and session formats: Chicago here we come! J. Rick Turner, PhD, DSc, FASH, FACC, FESC Interim Editor-in-Chief, TIRS
